The Sickle Cell Disease Association of America is extending efforts to increase and diversify participation rates of underrepresented demographics in clinical trials through their C.A.R.E.S. Consortium initiative.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
